Related Experiment Videos
[A vasoactive peptide: urotensin II].
Guo-Qiang Liu1, Zheng-Pei Zeng
1Department of Endocrinology, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
|September 24, 2005
Summary
Urotensin II (U II), a potent vasoconstrictor, and its receptor GPR-14 are reviewed. Their roles in vascular smooth muscle cell proliferation and vasoconstriction, including mechanisms, are detailed.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Molecular Biology
Context:
- Urotensin II (U II) is recognized as the most potent endogenous vasoconstrictor.
- G-protein coupled receptor 14 (GPR-14) serves as the specific receptor for U II.
- Understanding the U II/GPR-14 axis is crucial for cardiovascular research.
Purpose:
- To comprehensively review the structure and distribution of Urotensin II and GPR-14.
- To elucidate the activities mediated by the U II/GPR-14 interaction, focusing on vascular effects.
- To describe the underlying molecular mechanisms of U II and GPR-14 actions.
Summary:
- This review details the structural characteristics and tissue distribution of Urotensin II and its receptor, GPR-14.
- It examines the physiological activities of U II and GPR-14, particularly their roles in stimulating vascular smooth muscle cell proliferation.
- The review also covers the mechanisms by which U II and GPR-14 induce vasoconstriction.
Impact:
- Provides a foundational understanding of the Urotensin II signaling pathway in the vasculature.
- Highlights potential therapeutic targets for cardiovascular diseases associated with vasoconstriction and smooth muscle proliferation.
- Enhances knowledge of peptide hormone receptor interactions and their physiological consequences.